Asia-Pacific eClinical Solutions Market – Industry Trends and Forecast to 2026

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET: GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.7 DBMR MARKET POSITION GRID

2.8 MULTIVARIATE MODELING

2.9 PRODUCTS LIFELINE CURVE

2.10 SECONDARY SOURCES

2.11 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 INCREASING ADOPTION OF CLINICAL TRIALS

3.1.2 RISING GOVERNMENT INITIATIVES

3.1.3 GROWING NUMBER OF CONTRACT RESEARCH ORGANIZATION

3.1.4 INCREASE IN R & D EXPENDITURE BY PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES

3.2 RESTRAINTS

3.2.1 DEARTH OF TRAINED PROFESSIONALS

3.2.2 HIGH IMPLEMENTATION COST

3.3 OPPORTUNITIES

3.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS

3.3.2 TECHNOLOGICAL ADVANCEMENT

3.4 CHALLENGES

3.4.1 STRINGENT REGULATIONS

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY PRODUCT

6.1 OVERVIEW

6.2 ELECTRONIC DATA CAPTURE (EDC) AND CLINICAL DATA MANAGEMENT SYSTEMS (CDMS)

6.3 RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM)

6.4 CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS)

6.5 ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA)

6.6 ELECTRONIC TRIAL MASTER FILE SYSTEM

6.7 SAFETY SOLUTIONS

6.8 REGULATORY INFORMATION MANAGEMENT SOLUTIONS

6.9 CLINICAL DATA INTEGRATION PLATFORMS

6.10 CLINICAL ANALYTICS PLATFORMS

6.11 OTHER ECLINICAL SOLUTIONS

7 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE

7.1 OVERVIEW

7.2 WEB-HOSTED (ON-DEMAND) SOLUTIONS

7.3 CLOUD-BASED (SAAS) SOLUTIONS

7.4 LICENSED ENTERPRISE (ON-PREMISE) SOLUTIONS

8 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE

8.1 OVERVIEW

8.2 PHASE III

8.3 PHASE II

8.4 PHASE IV

8.5 PHASE I

9 ASIA-PACIFIC ECLINICAL SOLUTIONSMARKET, BY END USER

9.1 OVERVIEW

9.2 HOSPITALS/HEALTHCARE PROVIDERS

9.3 CONTRACT RESEARCH ORGANIZATIONS (CROS)

9.4 ACADEMIC INSTITUTES

9.5 PHARMA & BIOTECH ORGANIZATIONS

9.6 MEDICAL DEVICE MANUFACTURERS

9.7 CONSULTING SERVICE COMPANIES

10 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY GEOGRAPHY

10.1 ASIA-PACIFIC

10.1.1 JAPAN

10.1.2 CHINA

10.1.3 INDIA

10.1.4 SOUTH KOREA

10.1.5 AUSTRALIA

10.1.6 SINGAPORE

10.1.7 THAILAND

10.1.8 MALAYSIA

10.1.9 INDONESIA

10.1.10 PHILIPPINES

10.1.11 REST OF ASIA-PACIFIC

11 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, COMPANY LANDSCAPE

11.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC

12 COMPANY PROFILE

12.1 ORACLE

12.1.1 COMPANY SNAPSHOT

12.1.2 REVENUE ANALYSIS

12.1.3 COMPANY SHARE ANALYSIS

12.1.4 PRODUCT PORTFOLIO

12.1.5 RECENT DEVELOPMENTS

12.2 MEDIDATA SOLUTIONS

12.2.1 COMPANY SNAPSHOT

12.2.2 REVENUE ANALYSIS

12.2.3 COMPANY SHARE ANALYSIS

12.2.4 PRODUCT PORTFOLIO

12.2.5 RECENT DEVELOPMENT

12.3 PAREXEL INTERNATIONAL CORPORATION

12.3.1 COMPANY SNAPSHOT

12.3.2 COMPANY SHARE ANALYSIS

12.3.3 PRODUCT PORTFOLIO

12.3.4 RECENT DEVELOPMENTS

12.4 BIOCLINICA

12.4.1 COMPANY SNAPSHOT

12.4.2 PRODUCT PORTFOLIO

12.4.3 RECENT DEVELOPMENTS

12.5 ERT CLINICAL

12.5.1 COMPANY SNAPSHOT

12.5.2 PRODUCT PORTFOLIO

12.5.3 RECENT DEVELOPMENTS

12.6 ARIS ASIA-PACIFIC

12.6.1 COMPANY SNAPSHOT

12.6.2 PRODUCT PORTFOLIO

12.6.3 RECENT DEVELOPMENTS

12.7 ADVARRA

12.7.1 COMPANY SNAPSHOT

12.7.2 PRODUCT PORTFOLIO

12.7.3 RECENT DEVELOPMENTS

12.8 ANJU SOFTWARE

12.8.1 COMPANY SNAPSHOT

12.8.2 PRODUCT PORTFOLIO

12.8.3 RECENT DEVELOPMENTS

12.9 BIO-OPTRONICS, INC

12.9.1 COMPANY SNAPSHOT

12.9.2 PRODUCT PORTFOLIO

12.9.3 RECENT DEVELOPMENTS

12.10 DATATRAK INT.

12.10.1 COMPANY SNAPSHOT

12.10.2 REVENUE ANALYSIS

12.10.3 SOLUTION PORTFOLIO

12.10.4 RECENT DEVELOPMENTS

12.11 ECLINICALWORKS

12.11.1 COMPANY SNAPSHOT

12.11.2 PRODUCT PORTFOLIO

12.11.3 RECENT DEVELOPMENTS

12.12 ECLINICAL SOLUTIONS LLC

12.12.1 COMPANY SNAPSHOT

12.12.2 PRODUCT PORTFOLIO

12.12.3 RECENT DEVELOPMENTS

12.13 IBM CORPORATION

12.13.1 COMPANY SNAPSHOT

12.13.2 REVENUE ANALYSIS

12.13.3 PRODUCT PORTFOLIO

12.13.4 RECENT DEVELOPMENT

12.14 ICON PLC

12.14.1 COMPANY SNAPSHOT

12.14.2 REVENUE ANALYSIS

12.14.3 SERVICE PORTFOLIO

12.14.4 RECENT DEVELOPMENTS

12.15 MASTERCONTROL, INC.

12.15.1 COMPANY SNAPSHOT

12.15.2 SOLUTION PORTFOLIO

12.15.3 RECENT DEVELOPMENTS

12.16 MAXISIT

12.16.1 COMPANY SNAPSHOT

12.16.2 PRODUCT PORTFOLIO

12.16.3 RECENT DEVELOPMENT

12.17 OMNICOMM SYSTEMS, INC

12.17.1 COMPANY SNAPSHOT

12.17.2 REVENUE ANALYSIS

12.17.3 PRODUCT PORTFOLIO

12.17.4 RECENT DEVELOPMENTS

12.18 RESONANCE HEALTH

12.18.1 COMPANY SNAPSHOT

12.18.2 REVENUE ANALYSIS

12.18.3 PRODUCT PORTFOLIO

12.18.4 RECENT DEVELOPMENTS

12.19 REALTIME

12.19.1 COMPANY SNAPSHOT

12.19.2 PRODUCT PORTFOLIO

12.19.3 RECENT DEVELOPMENT

12.20 SIGNANT HEALTH

12.20.1 COMPANY SNAPSHOT

12.20.2 SOLUTION PORTFOLIO

12.20.3 RECENT DEVELOPMENTS

12.21 VEEVA SYSTEMS

12.21.1 COMPANY SNAPSHOT

12.21.2 REVENUE ANALYSIS

12.21.3 COMPANY SHARE ANALYSIS

12.21.4 PRODUCT PORTFOLIO

12.21.5 RECENT DEVELOPMENT

12.22 XYBION CORPORATION

12.22.1 COMPANY SNAPSHOT

12.22.2 PRODUCT PORTFOLIO

12.22.3 RECENT DEVELOPMENTS

13 QUESTIONNAIRE

14 RELATED REPORTS

UU

TABLE 1 CLINICAL TRIAL CONDUCTED IN DIFFERENT LOCATIONS

TABLE 2 TOP 20 PHARMA COMPANIES BY SIZE OF PIPELINE

TABLE 3 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 4 ASIA-PACIFIC ELECTRONIC DATA CAPTURE (EDC) AND CLINICAL DATA MANAGEMENT SYSTEMS (CDMS) IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 5 ASIA-PACIFIC RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 6 ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS) IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 7 ASIA-PACIFIC ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 8 ASIA-PACIFIC ELECTRICAL TRIAL MASTER FILE SYSTEM IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 9 ASIA-PACIFIC SAFETY SOLUTIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 10 ASIA-PACIFIC REGULATORY INFORMATION MANAGEMENT SOLUTIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 11 ASIA-PACIFIC CLINICAL DATA INTEGRATION PLATFORMS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 12 ASIA-PACIFIC CLINICAL ANALYTICS PLATFORMS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 13 ASIA-PACIFIC OTHER ECLINICAL SOLUTIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 14 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)

TABLE 15 ASIA-PACIFIC WEB-HOSTED (ON-DEMAND) SOLUTIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 16 ASIA-PACIFIC CLOUD-BASED (SAAS) SOLUTIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 17 ASIA-PACIFIC LICENSED ENTERPRISE (ON-PREMISE) SOLUTIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 18 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)

TABLE 19 ASIA-PACIFIC PHASE III IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 20 ASIA-PACIFIC PHASE II IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 21 ASIA-PACIFIC PHASE IV IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 22 ASIA-PACIFIC PHASE I IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 23 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 24 ASIA-PACIFIC HOSPITALS/HEALTHCARE PROVIDERS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 25 ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATIONS (CROS) IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 26 ASIA-PACIFIC ACADEMIC INSTITUTES COMPANIES IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 27 ASIA-PACIFIC PHARMA & BIOTECH ORGANIZATIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 28 ASIA-PACIFIC MEDICAL DEVICE MANUFACTURERS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 29 ASIA-PACIFIC CONSULTING SERVICE COMPANIES IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 30 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)

TABLE 31 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 32 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)

TABLE 33 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)

TABLE 34 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 35 JAPAN ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 36 JAPAN ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)

TABLE 37 JAPAN ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)

TABLE 38 JAPAN ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 39 CHINA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 40 CHINA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)

TABLE 41 CHINA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)

TABLE 42 CHINA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 43 INDIA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 44 INDIA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)

TABLE 45 INDIA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)

TABLE 46 INDIA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 47 SOUTH KOREA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 48 SOUTH KOREA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)

TABLE 49 SOUTH KOREA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)

TABLE 50 SOUTH KOREA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 51 AUSTRALIA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 52 AUSTRALIA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)

TABLE 53 AUSTRALIA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)

TABLE 54 AUSTRALIA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 55 SINGAPORE ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 56 SINGAPORE ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)

TABLE 57 SINGAPORE ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)

TABLE 58 SINGAPORE ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 59 THIALAND ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 60 THIALAND ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)

TABLE 61 THIALAND ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)

TABLE 62 THIALAND ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 63 MALAYSIA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 64 MALAYSIA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)

TABLE 65 MALAYSIA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)

TABLE 66 MALAYSIA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 67 INDONESIA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 68 INDONESIA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)

TABLE 69 INDONESIA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)

TABLE 70 INDONESIA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 71 PHILIPPINES ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

TABLE 72 PHILIPPINES ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)

TABLE 73 PHILIPPINES ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)

TABLE 74 PHILIPPINES ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 75 REST OF ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)